Logo image of H6D0.DE

HALEON PLC (H6D0.DE) Stock Fundamental Analysis

FRA:H6D0 - Deutsche Boerse Ag - GB00BMX86B70 - Common Stock - Currency: EUR

4.331  +0.05 (+1.26%)

Fundamental Rating

3

Overall H6D0 gets a fundamental rating of 3 out of 10. We evaluated H6D0 against 52 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of H6D0 while its profitability can be described as average. H6D0 has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year H6D0 was profitable.
H6D0 had a positive operating cash flow in the past year.
In the past 5 years H6D0 has always been profitable.
In the past 5 years H6D0 always reported a positive cash flow from operatings.
H6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFH6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

With a Return On Assets value of 4.20%, H6D0 perfoms like the industry average, outperforming 44.23% of the companies in the same industry.
With a Return On Equity value of 8.92%, H6D0 perfoms like the industry average, outperforming 48.08% of the companies in the same industry.
H6D0 has a Return On Invested Capital (6.11%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for H6D0 is significantly below the industry average of 14.50%.
Industry RankSector Rank
ROA 4.2%
ROE 8.92%
ROIC 6.11%
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
H6D0.DE Yearly ROA, ROE, ROICH6D0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

With a Profit Margin value of 12.84%, H6D0 perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
H6D0's Profit Margin has improved in the last couple of years.
H6D0's Operating Margin of 21.31% is in line compared to the rest of the industry. H6D0 outperforms 53.85% of its industry peers.
In the last couple of years the Operating Margin of H6D0 has grown nicely.
H6D0 has a Gross Margin of 60.75%. This is in the lower half of the industry: H6D0 underperforms 63.46% of its industry peers.
H6D0's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.31%
PM (TTM) 12.84%
GM 60.75%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
H6D0.DE Yearly Profit, Operating, Gross MarginsH6D0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so H6D0 is destroying value.
H6D0 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for H6D0 has been reduced compared to 5 years ago.
H6D0 has a worse debt/assets ratio than last year.
H6D0.DE Yearly Shares OutstandingH6D0.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
H6D0.DE Yearly Total Debt VS Total AssetsH6D0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

H6D0 has an Altman-Z score of 1.76. This is a bad value and indicates that H6D0 is not financially healthy and even has some risk of bankruptcy.
H6D0 has a worse Altman-Z score (1.76) than 63.46% of its industry peers.
The Debt to FCF ratio of H6D0 is 5.11, which is a neutral value as it means it would take H6D0, 5.11 years of fcf income to pay off all of its debts.
H6D0 has a Debt to FCF ratio (5.11) which is comparable to the rest of the industry.
H6D0 has a Debt/Equity ratio of 0.53. This is a neutral value indicating H6D0 is somewhat dependend on debt financing.
The Debt to Equity ratio of H6D0 (0.53) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.11
Altman-Z 1.76
ROIC/WACC0.83
WACC7.32%
H6D0.DE Yearly LT Debt VS Equity VS FCFH6D0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 0.98 indicates that H6D0 may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.98, H6D0 is doing worse than 75.00% of the companies in the same industry.
A Quick Ratio of 0.78 indicates that H6D0 may have some problems paying its short term obligations.
H6D0 has a Quick ratio of 0.78. This is in the lower half of the industry: H6D0 underperforms 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.78
H6D0.DE Yearly Current Assets VS Current LiabilitesH6D0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.59% over the past year.
The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
Looking at the last year, H6D0 shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
Measured over the past years, H6D0 shows a small growth in Revenue. The Revenue has been growing by 5.78% on average per year.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%32.07%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.25%

3.2 Future

H6D0 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.34% yearly.
H6D0 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.41% yearly.
EPS Next Y9.06%
EPS Next 2Y8.99%
EPS Next 3Y8.81%
EPS Next 5Y8.34%
Revenue Next Year0.74%
Revenue Next 2Y2.54%
Revenue Next 3Y3.21%
Revenue Next 5Y3.41%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
H6D0.DE Yearly Revenue VS EstimatesH6D0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
H6D0.DE Yearly EPS VS EstimatesH6D0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0.05 0.1 0.15 0.2 0.25

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.62, which indicates a rather expensive current valuation of H6D0.
Compared to the rest of the industry, the Price/Earnings ratio of H6D0 is on the same level as its industry peers.
When comparing the Price/Earnings ratio of H6D0 to the average of the S&P500 Index (27.47), we can say H6D0 is valued slightly cheaper.
The Price/Forward Earnings ratio is 19.14, which indicates a rather expensive current valuation of H6D0.
H6D0's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.91, H6D0 is valued at the same level.
Industry RankSector Rank
PE 20.62
Fwd PE 19.14
H6D0.DE Price Earnings VS Forward Price EarningsH6D0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

H6D0's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. H6D0 is cheaper than 71.15% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, H6D0 is valued cheaper than 90.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.46
EV/EBITDA 9.07
H6D0.DE Per share dataH6D0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.28
PEG (5Y)1.17
EPS Next 2Y8.99%
EPS Next 3Y8.81%

More info and screens

2

5. Dividend

5.1 Amount

H6D0 has a Yearly Dividend Yield of 1.77%.
Compared to an average industry Dividend Yield of 3.05, H6D0 has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.37, H6D0 is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.77%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
H6D0.DE Yearly Dividends per shareH6D0.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DPN/A
EPS Next 2Y8.99%
EPS Next 3Y8.81%
H6D0.DE Yearly Income VS Free CF VS DividendH6D0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

HALEON PLC

FRA:H6D0 (7/10/2025, 7:00:00 PM)

4.331

+0.05 (+1.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-30 2025-04-30
Earnings (Next)07-31 2025-07-31
Inst Owners56.28%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap19.45B
Analysts78.46
Price Target5.22 (20.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.77%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.37%
PT rev (3m)1.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.92%
Valuation
Industry RankSector Rank
PE 20.62
Fwd PE 19.14
P/S 1.49
P/FCF 8.46
P/OCF 7.29
P/B 1.04
P/tB N/A
EV/EBITDA 9.07
EPS(TTM)0.21
EY4.85%
EPS(NY)0.23
Fwd EY5.22%
FCF(TTM)0.51
FCFY11.82%
OCF(TTM)0.59
OCFY13.71%
SpS2.9
BVpS4.17
TBVpS-2.59
PEG (NY)2.28
PEG (5Y)1.17
Profitability
Industry RankSector Rank
ROA 4.2%
ROE 8.92%
ROCE 8.4%
ROIC 6.11%
ROICexc 6.63%
ROICexgc 4145.85%
OM 21.31%
PM (TTM) 12.84%
GM 60.75%
FCFM 17.65%
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.11
Debt/EBITDA 3.18
Cap/Depr 98.15%
Cap/Sales 2.83%
Interest Coverage 6.65
Cash Conversion 84.66%
Profit Quality 137.52%
Current Ratio 0.98
Quick Ratio 0.78
Altman-Z 1.76
F-Score6
WACC7.32%
ROIC/WACC0.83
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%32.07%
EPS Next Y9.06%
EPS Next 2Y8.99%
EPS Next 3Y8.81%
EPS Next 5Y8.34%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.25%
Revenue Next Year0.74%
Revenue Next 2Y2.54%
Revenue Next 3Y3.21%
Revenue Next 5Y3.41%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year13.76%
EBIT Next 3Y8.96%
EBIT Next 5Y6.64%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%